You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Venetoclax

Showing 301 - 325 of 485
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myelogenous Leukemia Trial in Rochester, Milwaukee (Azacitidine, Venetoclax, Pevonedistat)

Active, not recruiting
  • Acute Myelogenous Leukemia
  • Rochester, Minnesota
  • +1 more
Sep 21, 2021

Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (Venetoclax, Polatuzumab Vedotin, Rituximab)

Recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • Venetoclax
  • +5 more
  • New York, New York
  • +19 more
Aug 17, 2022

Acute Myeloid Leukemia (AML) Trial in Germany, United Kingdom, United States (Venetoclax, Alvocidib)

Completed
  • Acute Myeloid Leukemia (AML)
  • Los Angeles, California
  • +13 more
Jan 24, 2022

Venetoclax for Chronic Lymphocytic Leukemia Used in Routine

Recruiting
  • Cancer, Chronic Lymphocytic Leukemia (CLL)
    • Seoul, Seoul Teugbyeolsi, Korea, Republic of
    • +7 more
    Mar 17, 2022

    Chronic Lymphocytic Leukemia, Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 30, 2021

    Leukemia, Myeloid Trial in Worldwide (CC-90011, Venetoclax, Azacitidine)

    Completed
    • Leukemia, Myeloid
    • Duarte, California
    • +34 more
    Apr 26, 2022

    Acute Myeloid Leukemia (AML) Trial in China (Venetoclax, Azacitidine)

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • Beijing, Beijing, China
    • +23 more
    Aug 12, 2022

    Cancer - Acute Myeloid Leukemia Trial in Australia, Spain, United States (Venetoclax, Dinaciclib)

    Active, not recruiting
    • Cancer - Acute Myeloid Leukemia
    • Little Rock, Arkansas
    • +12 more
    Dec 29, 2021

    Disease State in Adult Acute Myeloid Leukemia Ineligible for

    Not yet recruiting
    • Acute Myeloid Leukemia
      • Calgary, Alberta, Canada
      • +9 more
      Jun 15, 2022

      Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

      Recruiting
      • Acute Biphenotypic Leukemia
      • +13 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 19, 2023

      Relapsed Non Hodgkin Lymphoma Trial in Worldwide (Venetoclax)

      Active, not recruiting
      • Relapsed Non Hodgkin Lymphoma
      • Venetoclax
      • Aalborg, Denmark
      • +16 more
      Oct 12, 2021

      CLL Trial in Denmark, Netherlands, Sweden (Acalabrutinib, Venetoclax)

      Recruiting
      • CLL
      • Copenhagen, Denmark
      • +5 more
      Sep 17, 2021

      Hematologic Malignancy, Older Patients, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Hangzhou, Ningbo, Wenzhou

      Recruiting
      • Hematologic Malignancy
      • +2 more
      • venetoclax combining with fludarabine and melphalan
      • Hangzhou, Zhejiang, China
      • +7 more
      Oct 20, 2021

      Acute Myeloid Leukemia (AML) Trial in United States (Alvocidib (flavopiridol) and cytarabine (Ara-C), Alvocidib (flavopiridol))

      Terminated
      Has Results
      • Acute Myeloid Leukemia (AML)
      • Alvocidib (flavopiridol) and cytarabine (Ara-C)
      • Alvocidib (flavopiridol)
      • Clovis, California
      • +17 more
      Sep 22, 2022

      Acute Myeloid Leukemia Trial in Lanzhou (Venetoclax, Azacitidine, Cladribine)

      Recruiting
      • Acute Myeloid Leukemia
      • Venetoclax
      • +4 more
      • Lanzhou, Gansu, China
        Long Zhao
      Apr 24, 2022

      Chronic Lymphoid Leukemia in Relapse Trial in Tuebingen (Belimumab 200 MG/ML [Benlysta], standard of care)

      Recruiting
      • Chronic Lymphoid Leukemia in Relapse
      • Belimumab 200 MG/ML [Benlysta]
      • standard of care
      • Tuebingen, BW, Germany
        University Hospital Tuebingen, CCU Translational Immunology
      Feb 2, 2022

      Diffuse Large B-cell Lymphoma, High-Grade B-cell Lymphoma Trial in Worldwide (RO6870810, Venetoclax, Rituximab)

      Completed
      • Diffuse Large B-cell Lymphoma
      • High-Grade B-cell Lymphoma
      • Duarte, California
      • +8 more
      Jan 21, 2022

      Oral Venetoclax Tablets in Combination With Intravenous

      Terminated
      • Chronic Lymphocytic Leukemia (CLL)
        • Moscow, Moskva, Russian Federation
        • +3 more
        Nov 18, 2021

        Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Worldwide (Lemzoparlimab, Azacitidine, Venetoclax)

        Recruiting
        • Acute Myeloid Leukemia (AML)
        • Myelodysplastic Syndrome (MDS)
        • Birmingham, Alabama
        • +35 more
        Aug 19, 2022

        Acute Myeloid Leukemia Trial in Hannover (Venetoclax)

        Recruiting
        • Acute Myeloid Leukemia
        • Venetoclax
        • Hannover, Niedersachsen, Germany
          Medical School Hannover
        Feb 15, 2021

        Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in La Jolla (Venetoclax, Ibrutinib)

        Active, not recruiting
        • Chronic Lymphocytic Leukemia
        • Small Lymphocytic Lymphoma
        • La Jolla, California
          UC San Diego Moores Cancer Center
        May 6, 2021

        CLL Trial in Denmark, Netherlands (ibrutinib, venetoclax, obinutuzumab, ibrutinib, venetoclax)

        Active, not recruiting
        • CLL
        • ibrutinib, venetoclax, obinutuzumab
        • ibrutinib, venetoclax
        • Aalborg, Denmark
        • +26 more
        Aug 20, 2021

        Leukemia, Lymphocytic, Chronic, B-Cell, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide

        Completed
        Has Results
        • Leukemia, Lymphocytic, Chronic, B-Cell
        • +2 more
        • Tafasitamab
        • +2 more
        • Jacksonville, Florida
        • +16 more
        Dec 10, 2021

        Acute Myeloid Leukemia (AML) Trial in United States (BP1001 in combination with Ventoclax plus decitabine, BP1001 plus

        Recruiting
        • Acute Myeloid Leukemia (AML)
        • BP1001 in combination with Ventoclax plus decitabine
        • BP1001 plus decitabine
        • Fairway, Kansas
        • +5 more
        Jan 3, 2022

        AML Trial (APVO436)

        Withdrawn
        • AML
        • APVO436
        • (no location specified)
        Nov 29, 2021